Peptide Partners
Updated Oct 17, 2026
01At a glance
Named lab · Lot COA · HPLC · Mass spec · Outside tested
Accessible
FDA warning letter, August 24 2026
The letter cites its semaglutide, tirzepatide and retatrutide products, SS-31, tesamorelin, PT-141 and its reconstitution solution. A letter does not mean a seller is dishonest or that its products are bad. Read more ↗
02Testing
Chromate, TrustPointe, Kovera and BioRegen
Named on the store's own pages
Says a certificate covers each lot.
The store does not say.
Independent test results on Finnrick ↗ · Sep 10, 2026
03Prices
Not enough comparable listings to compare prices.
0 comparable compound and size pairs
Carries 33 of our compounds (47 listings)
72% of listings in stock; prices checked 17 Oct 2026
| Compound | Lead size | Store $/mg | Market median $/mg | Difference |
|---|---|---|---|---|
| BPC-157 | 10 mg | Not comparable | $5.50 | Not comparable |
| GHK-Cu | 50 mg | Not comparable | $0.80 | Not comparable |
| Retatrutide | 10 mg | Not comparable | $7.95 | Not comparable |
| Semaglutide | 10 mg | Not comparable | $6.90 | Not comparable |
| TB-500 / Thymosin Beta-4 | 10 mg | Not comparable | $6.40 | Not comparable |
| KPV | 10 mg | Not comparable | $5.20 | Not comparable |
| MOTS-c | 10 mg | Not comparable | $5.00 | Not comparable |
| SS-31 (Elamipretide) | 10 mg | Not comparable | $5.10 | Not comparable |
| 5-Amino-1MQ | 50 mg | Not comparable | $1.60 | Not comparable |
| AOD-9604 | 5 mg | Not comparable | $9.80 | Not comparable |
| Cagrilintide | 10 mg | Not comparable | $10.00 | Not comparable |
| CJC-1295 no DAC (Mod GRF 1-29) | 5 mg | Not comparable | $7.80 | Not comparable |
| DSIP (Delta Sleep-Inducing Peptide) | 5 mg | Not comparable | $7.00 | Not comparable |
| Epitalon | 10 mg | Not comparable | $4.00 | Not comparable |
| Humanin | 10 mg | Not comparable | $13.03 | Not comparable |
| Ipamorelin | 10 mg | Not comparable | $5.50 | Not comparable |
| Ipamorelin + CJC-1295 (no DAC) blend | 10 mg | Not comparable | $6.00 | Not comparable |
| KLOW blend | 80 mg | Not comparable | $1.50 | Not comparable |
| NAD+ | 500 mg | Not comparable | $0.14 | Not comparable |
| Pinealon | 10 mg | Not comparable | $4.70 | Not comparable |
| PT-141 (Bremelanotide) | 10 mg | Not comparable | $4.30 | Not comparable |
| Selank | 10 mg | Not comparable | $4.50 | Not comparable |
| Semax | 10 mg | Not comparable | $4.50 | Not comparable |
| Sermorelin | 10 mg | Not comparable | $6.90 | Not comparable |
| Tesamorelin | 10 mg | Not comparable | $7.40 | Not comparable |
| Thymosin Alpha-1 | 10 mg | Not comparable | $7.00 | Not comparable |
| Tirzepatide | 10 mg | Not comparable | $7.00 | Not comparable |
| VIP (Vasoactive Intestinal Peptide) | 10 mg | Not comparable | $6.80 | Not comparable |
04Vendor Watch
fda_warning_letter · FDA CDER
Peptide Partners LLC
Reference 735063 read from the fda.gov index; the letter was opened by the script and reviewed peptide.partners, so the host match is confirmed.
scraped · Read Sep 23, 2026
Site answered Nov 1, 2026
05Company and payment
How you can pay
Accepts credit cards: Not stated before checkout
Not stated before checkout
Who's behind it
Peptide Partners LLC
8350 Bee Ridge #379, Sarasota, FL 34241 (a numbered mailbox; address as given in FDA letter 735063)
FDA warning letter 735063 (August 24, 2026, posted September 1) after a July 2026 review of peptide.partners; it cites its semaglutide, tirzepatide and retatrutide products, SS-31, tesamorelin, PT-141 and its reconstitution solution. The letter was also addressed to a second Sarasota company
06Dates
- Prices last read
- Oct 17, 2026
- Profile last reviewed
- Oct 19, 2026
- Slice generated
- Nov 2, 2026